卡塔林·考里科 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "卡塔林·考里科" in Chinese language version.

refsWebsite

Global rank Chinese rank

13web.archive.org

1^st place

5nih.gov

4^th place

5^th place

5doi.org

2^nd place

23^rd place

2semanticscholar.org

11^th place

332^nd place

2theguardian.com

12^th place

60^th place

1mrna-conference.com

low place

1sciencedirect.com

149^th place

292^nd place

1oup.com

485^th place

489^th place

1elsevier.com

610^th place

388^th place

1statnews.com

8,771^st place

9,752^nd place

1cuhk.edu.hk

3,232^nd place

151^st place

1laskerfoundation.org

low place

1time.com

61^st place

145^th place

1tang-prize.org

low place

9,978^th place

1upenn.edu

702^nd place

1,153^rd place

1wired.co.uk

2,053^rd place

3,984^th place

1hungarianfreepress.com

low place

1salon.com

456^th place

1,212^th place

1goodnewsnetwork.org

low place

cuhk.edu.hk (Global: 3,232^nd place; Chinese: 151^st place)

cpr.cuhk.edu.hk

存档副本. [2023-10-03]. （原始内容存档于2023-10-08）.

doi.org (Global: 2^nd place; Chinese: 23^rd place)

Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.
Karikó, Katalin; Buckstein, MIchael; Ni, Houping; Weissman, Drew. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity. 2005-08-01, 23 (2): 165–175 [2021-04-16]. PMID 16111635. doi:10.1016/j.immuni.2005.06.008. （原始内容存档于2021-04-14）（英语）.
Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Karikó K. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research. September 2010, 38 (17): 5884–92 [2021-04-16]. PMC 2943593 . PMID 20457754. doi:10.1093/nar/gkq347. （原始内容存档于2021-02-25）.
Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy. November 2008, 16 (11): 1833–40 [2021-04-16]. PMC 2775451 . PMID 18797453. doi:10.1038/mt.2008.200. （原始内容存档于2021-02-24）.
Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.

elsevier.com (Global: 610^th place; Chinese: 388^th place)

linkinghub.elsevier.com

Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy. November 2008, 16 (11): 1833–40 [2021-04-16]. PMC 2775451 . PMID 18797453. doi:10.1038/mt.2008.200. （原始内容存档于2021-02-24）.

goodnewsnetwork.org (Global: low place; Chinese: low place)

Corbly, Andy. She was Demoted, Doubted and Rejected But Now Her Work is the Basis of the Covid-19 Vaccine. Good News Network. 2021-02-01 [2021-02-02]. （原始内容存档于2021-05-20）（美国英语）.

hungarianfreepress.com (Global: low place; Chinese: low place)

Katalin Karikó and Drew Weissman. A shared Nobel-prize for mRNA?. Hungarian Free Press. 2020-12-19 [2021-01-29]. （原始内容存档于2021-02-18）（美国英语）.

laskerfoundation.org (Global: low place; Chinese: low place)

Admin, Lasker. Modified mRNA vaccines. Lasker Foundation. [2025-03-28] （美国英语）.

mrna-conference.com (Global: low place; Chinese: low place)

Katalin Karikó. 8th International mRNA Health Conference. [2021-01-10]. （原始内容存档于2020-12-12）（美国英语）.

nih.gov (Global: 4^th place; Chinese: 5^th place)

ncbi.nlm.nih.gov

Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.
Karikó, Katalin; Buckstein, MIchael; Ni, Houping; Weissman, Drew. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity. 2005-08-01, 23 (2): 165–175 [2021-04-16]. PMID 16111635. doi:10.1016/j.immuni.2005.06.008. （原始内容存档于2021-04-14）（英语）.
Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Karikó K. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research. September 2010, 38 (17): 5884–92 [2021-04-16]. PMC 2943593 . PMID 20457754. doi:10.1093/nar/gkq347. （原始内容存档于2021-02-25）.
Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy. November 2008, 16 (11): 1833–40 [2021-04-16]. PMC 2775451 . PMID 18797453. doi:10.1038/mt.2008.200. （原始内容存档于2021-02-24）.
Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.

oup.com (Global: 485^th place; Chinese: 489^th place)

academic.oup.com

Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Karikó K. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research. September 2010, 38 (17): 5884–92 [2021-04-16]. PMC 2943593 . PMID 20457754. doi:10.1093/nar/gkq347. （原始内容存档于2021-02-25）.

salon.com (Global: 456^th place; Chinese: 1,212^th place)

Rosza, Matthew. The hero biochemist who pioneered COVID vaccine tech was professionally spurned for years prior. Salon. 2021-01-25 [2021-02-02]. （原始内容存档于2021-08-16）（英语）.

sciencedirect.com (Global: 149^th place; Chinese: 292^nd place)

Karikó, Katalin; Buckstein, MIchael; Ni, Houping; Weissman, Drew. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity. 2005-08-01, 23 (2): 165–175 [2021-04-16]. PMID 16111635. doi:10.1016/j.immuni.2005.06.008. （原始内容存档于2021-04-14）（英语）.

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

api.semanticscholar.org

Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.
Keener AB. Just the messenger. Nature Medicine. September 2018, 24 (9): 1297–1300. PMID 30139958. S2CID 52074565. doi:10.1038/s41591-018-0183-7.

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

Garde, Damian; Saltzman, Jonathan. The story of mRNA: From a loose idea to a tool that may help curb Covid. STAT. 2020-11-10 [2021-01-10]. （原始内容存档于2020-11-26）（美国英语）.

tang-prize.org (Global: low place; Chinese: 9,978^th place)

Tang Prize | Media | 2022 Tang Prize in Biopharmaceutical Science Honors Three Scientists for Developing COVID-19 mRNA Vaccines. www.tang-prize.org. [2025-03-28] （英语）.

theguardian.com (Global: 12^th place; Chinese: 60^th place)

Kollewe, Julia. Covid vaccine technology pioneer: 'I never doubted it would work'. The Guardian. 2020-11-21 [2020-11-22]. （原始内容存档于2021-04-11）.
Kollewe, Julia. Covid vaccine technology pioneer: 'I never doubted it would work'. The Guardian. 2020-11-21 [2020-11-22]. （原始内容存档于2021-04-11）.

time.com (Global: 61^st place; Chinese: 145^th place)

Vaccine Scientists Are TIME's 2021 Heroes of the Year. Time. 2021-12-13 [2025-03-28] （英语）.

upenn.edu (Global: 702^nd place; Chinese: 1,153^rd place)

med.upenn.edu

University of Pennsylvania’s Perelman School of Medicine. [2021-09-14]. （原始内容存档于2021-10-23）.

web.archive.org (Global: 1^st place; Chinese: 1^st place)

Katalin Karikó. 8th International mRNA Health Conference. [2021-01-10]. （原始内容存档于2020-12-12）（美国英语）.
Karikó, Katalin; Buckstein, MIchael; Ni, Houping; Weissman, Drew. Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity. 2005-08-01, 23 (2): 165–175 [2021-04-16]. PMID 16111635. doi:10.1016/j.immuni.2005.06.008. （原始内容存档于2021-04-14）（英语）.
Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Karikó K. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research. September 2010, 38 (17): 5884–92 [2021-04-16]. PMC 2943593 . PMID 20457754. doi:10.1093/nar/gkq347. （原始内容存档于2021-02-25）.
Karikó K, Muramatsu H, Welsh FA, Ludwig J, Kato H, Akira S, Weissman D. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy. November 2008, 16 (11): 1833–40 [2021-04-16]. PMC 2775451 . PMID 18797453. doi:10.1038/mt.2008.200. （原始内容存档于2021-02-24）.
Kollewe, Julia. Covid vaccine technology pioneer: 'I never doubted it would work'. The Guardian. 2020-11-21 [2020-11-22]. （原始内容存档于2021-04-11）.
Garde, Damian; Saltzman, Jonathan. The story of mRNA: From a loose idea to a tool that may help curb Covid. STAT. 2020-11-10 [2021-01-10]. （原始内容存档于2020-11-26）（美国英语）.
存档副本. [2023-10-03]. （原始内容存档于2023-10-08）.
University of Pennsylvania’s Perelman School of Medicine. [2021-09-14]. （原始内容存档于2021-10-23）.
Kollewe, Julia. Covid vaccine technology pioneer: 'I never doubted it would work'. The Guardian. 2020-11-21 [2020-11-22]. （原始内容存档于2021-04-11）.
Cox, David. How mRNA went from a scientific backwater to a pandemic crusher. Wired. 2020-12-02 [2020-12-26]. （原始内容存档于2020-12-27）.
Katalin Karikó and Drew Weissman. A shared Nobel-prize for mRNA?. Hungarian Free Press. 2020-12-19 [2021-01-29]. （原始内容存档于2021-02-18）（美国英语）.
Rosza, Matthew. The hero biochemist who pioneered COVID vaccine tech was professionally spurned for years prior. Salon. 2021-01-25 [2021-02-02]. （原始内容存档于2021-08-16）（英语）.
Corbly, Andy. She was Demoted, Doubted and Rejected But Now Her Work is the Basis of the Covid-19 Vaccine. Good News Network. 2021-02-01 [2021-02-02]. （原始内容存档于2021-05-20）（美国英语）.

wired.co.uk (Global: 2,053^rd place; Chinese: 3,984^th place)

Cox, David. How mRNA went from a scientific backwater to a pandemic crusher. Wired. 2020-12-02 [2020-12-26]. （原始内容存档于2020-12-27）.

卡塔林·考里科 (Chinese Wikipedia)

cuhk.edu.hk (Global: 3,232nd place; Chinese: 151st place)

cpr.cuhk.edu.hk

doi.org (Global: 2nd place; Chinese: 23rd place)

elsevier.com (Global: 610th place; Chinese: 388th place)

linkinghub.elsevier.com

goodnewsnetwork.org (Global: low place; Chinese: low place)

hungarianfreepress.com (Global: low place; Chinese: low place)

laskerfoundation.org (Global: low place; Chinese: low place)

mrna-conference.com (Global: low place; Chinese: low place)

nih.gov (Global: 4th place; Chinese: 5th place)

ncbi.nlm.nih.gov

oup.com (Global: 485th place; Chinese: 489th place)

academic.oup.com

salon.com (Global: 456th place; Chinese: 1,212th place)

sciencedirect.com (Global: 149th place; Chinese: 292nd place)

semanticscholar.org (Global: 11th place; Chinese: 332nd place)

api.semanticscholar.org

statnews.com (Global: 8,771st place; Chinese: 9,752nd place)

tang-prize.org (Global: low place; Chinese: 9,978th place)

theguardian.com (Global: 12th place; Chinese: 60th place)

time.com (Global: 61st place; Chinese: 145th place)

upenn.edu (Global: 702nd place; Chinese: 1,153rd place)

med.upenn.edu

web.archive.org (Global: 1st place; Chinese: 1st place)

wired.co.uk (Global: 2,053rd place; Chinese: 3,984th place)

cuhk.edu.hk (Global: 3,232^nd place; Chinese: 151^st place)

doi.org (Global: 2^nd place; Chinese: 23^rd place)

elsevier.com (Global: 610^th place; Chinese: 388^th place)

nih.gov (Global: 4^th place; Chinese: 5^th place)

oup.com (Global: 485^th place; Chinese: 489^th place)

salon.com (Global: 456^th place; Chinese: 1,212^th place)

sciencedirect.com (Global: 149^th place; Chinese: 292^nd place)

semanticscholar.org (Global: 11^th place; Chinese: 332^nd place)

statnews.com (Global: 8,771^st place; Chinese: 9,752^nd place)

tang-prize.org (Global: low place; Chinese: 9,978^th place)

theguardian.com (Global: 12^th place; Chinese: 60^th place)

time.com (Global: 61^st place; Chinese: 145^th place)

upenn.edu (Global: 702^nd place; Chinese: 1,153^rd place)

web.archive.org (Global: 1^st place; Chinese: 1^st place)

wired.co.uk (Global: 2,053^rd place; Chinese: 3,984^th place)